» Articles » PMID: 39639933

From Geriatric Assessment to Inflammation. A Pilot, Observational, Study About Frailty Components in Older Patients with Persistent Atrial Fibrillation

Abstract

Background: Atrial fibrillation (AF) is the most common arrhythmia diagnosed at an older age. AF is associated with frailty, a condition possibly justifying the higher rate of complications and mortality in aged individuals. This study was aimed at describing the characteristics correlated to frailty in older AF subjects.

Methods: After having excluded a < 3 months major surgery procedure, cancer or other conditions associated with activation of inflammation, and a life expectancy < 12 months, we consecutively enrolled patients ≥ 65 years with persistent AF. They underwent a Comprehensive Geriatric Assessment evaluation. In particular, Mini-Mental State Examination, 15-item Geriatric Depression Scale and Short-Physical Performance Battery (SPPB) described, respectively, cognitive profile, depressive symptoms and physical performance. A venous blood sample was collected to measure interleukin-6 (IL-6; marker of low-grade inflammation) and acylcarnitines, expression of mitochondrial dysfunction and abnormal energy production.

Results: Overall, 49 patients (mean age: 76 ± 6 years; women 30.6 %) were studied. Cluster analysis described two different patterns; the second (N = 18, 36.7 %), when compared to the first one (N = 31, 63.3 %), was characterized by a worse phenotype, identified by the simultaneous presence of lower body mass index, higher CHADS-VASc score (index of clinical complexity), worse SPPB functional performance, and high IL-6 levels. Second cluster patients had a higher concentration of 13 of the 35 acylcarnitines evaluated and increased 5-year mortality. All these features can outline a frail condition.

Conclusions: Body size, clinical complexity, physical performance and low-grade inflammation seem to rapidly and adequately describe frailty.

References
1.
Ijaz N, Buta B, Xue Q, Mohess D, Bushan A, Tran H . Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022; 79(5):482-503. PMC: 8852369. DOI: 10.1016/j.jacc.2021.11.029. View

2.
Fumagalli S, Ricciardi G, Di Serio C, la Marca G, Pieraccini G, Franci Montorzi R . Inflammation, mitochondrial dysfunction and physical performance: a possible association in older patients with persistent atrial fibrillation-the results of a preliminary study. Aging Clin Exp Res. 2023; 35(11):2831-2837. DOI: 10.1007/s40520-023-02558-w. View

3.
Harrison S, Buckley B, Austin P, Lane D, Lip G . Catheter ablation and lower risk of incident dementia and mortality in older adults with atrial fibrillation. J Am Geriatr Soc. 2023; 71(11):3357-3366. DOI: 10.1111/jgs.18538. View

4.
Dambrova M, Makrecka-Kuka M, Kuka J, Vilskersts R, Nordberg D, Attwood M . Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials. Pharmacol Rev. 2022; 74(3):506-551. DOI: 10.1124/pharmrev.121.000408. View

5.
Balsrud P, Ulven S, Christensen J, Ottestad I, Holven K . Inflammatory markers and frailty in home-dwelling elderly, a cross-sectional study. BMC Geriatr. 2024; 24(1):175. PMC: 10877806. DOI: 10.1186/s12877-024-04690-2. View